Poor Adherence Is the Main Reason for Loss of CCyR and Imatinib Failure for CML Patients On Long Term Imatinib Therapy von Ibrahim, Amr R, Milojkovic, Dragana, Bua, Marco, Khorshad, Jamshid S, Szydlo, Richard, Eliasson, Lina, Foroni, Letizia, Reid, Alistair, Lavallade, Hugues de, Rezvani, Katayoun, Goldman, John M., Apperley, Jane, Marin, David

Volltext

Efficacy of Tyrosine Kinase Inhibitors (TKIs) as Third Line Therapy In Patients with Chronic Myeloid Leukaemia In Chronic Phase Who Have Failed Two Prior TKIs von Ibrahim, Amr R, Bua, Marco, Khorshad, Jamshid S, Milojkovic, Dragana, Eliasson, Lina, Szydlo, Richard, Foroni, Letizia, Reid, Alistair, de Lavallade, Hugues, Rezvani, Katayoun, Goldman, John M., Apperley, Jane, Marin, David

Volltext

How Best to Express the Results of Serial RQ-PCR Studies to Measure Minimal Residual Disease in Treated Leukaemia Patients? von Anand, Mona, Kaeda, Jaspal S., Szydlo, Richard, Khorshad, Jamshid S., Marin, David, Swale, Bryony, Saunders, Sue, Olavarria, Eduardo, Goldman, John M., Apperley, Jane F.

Volltext